Robert E. Slayton
Impact in
- Reproductive Medicine top 2%
- Ovarian cancer diagnosis and treatment
- Obstetrics and Gynecology top 5%
- Endometrial and Cervical Cancer Treatments
- Uterine Myomas and Treatments
Papers in
-
- Ovarian cancer diagnosis and treatment 15
-
- Endometrial and Cervical Cancer Treatments 9
- Uterine Myomas and Treatments 4
- Co-authors
- John A. Blessing (19 shared papers)Charles P. Perlia (5 shared papers)Arthur H. Rossof (4 shared papers)Hugh M. Shingleton (3 shared papers)Steven G. Silverberg (3 shared papers)Robert C. Park (1 shared paper)William Thomas Creasman (1 shared paper)Philip Bonomi (8 shared papers)
- Journals
- Cancer (7 papers)Gynecologic Oncology (6 papers)Investigational New Drugs (3 papers)Journal of Clinical Oncology (2 papers)Cancer Chemotherapy and Pharmacology (1 paper)
- Partner nations
- United StatesSingapore
In The Last Decade
Robert E. Slayton
46 papers receiving 898 citations
Peers
Comparison fields: 5 of 64
- Reproductive Medicine 320
- Obstetrics and Gynecology 168
- Surgery 225
- Toxicology 27
- Oncology 112
Countries citing papers authored by Robert E. Slayton
This map shows the geographic impact of Robert E. Slayton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert E. Slayton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert E. Slayton more than expected).
Fields of papers citing papers by Robert E. Slayton
This network shows the impact of papers produced by Robert E. Slayton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert E. Slayton. The network helps show where Robert E. Slayton may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert E. Slayton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1972 | 149 | |
| 2 | 1985 | 129 | |
| 3 | 1978 | 82 | |
| 4 | 1985 | 68 | |
| 5 | 1971 | 62 | |
| 6 | 1978 | 56 | |
| 7 | 1981 | 55 | |
| 8 | 1971 | 44 | |
| 9 | Phase II trial of VP-16-213 in the treatment of advanced squamous cell carcinoma of the cervix and adenocarcinoma of the ovary: a Gynecologic Oncology Group Study. | 1980 | 44 |
| 10 | 1985 | 35 | |
| 11 | Phase II trial of hexamethylmelamine in ovarian carcinoma resistant to alkylating agents. | 1979 | 33 |
| 12 | Megestrol acetate used as primary hormonal therapy in stage D prostatic cancer. | 1985 | 28 |
| 13 | Phase II trial of etoposide in the management of advanced and recurrent leiomyosarcoma of the uterus: a Gynecologic Oncology Group Study. | 1987 | 27 |
| 14 | Management of germ cell and stromal tumors of the ovary. | 1984 | 25 |
| 15 | Progestin therapy for advanced ovarian cancer: a phase II Eastern Cooperative Oncology Group trial. | 1981 | 23 |
| 16 | Phase II trial of etoposide in the management of advanced or recurrent mixed mesodermal sarcomas of the uterus: a Gynecologic Oncology Group Study. | 1987 | 21 |
| 17 | Phase II trial of etoposide in the management of advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group Study. | 1982 | 18 |
| 18 | 1991 | 16 | |
| 19 | 1989 | 15 | |
| 20 | 1979 | 13 |
About Robert E. Slayton
Robert E. Slayton is a scholar working on Reproductive Medicine, Obstetrics and Gynecology, Pulmonary and Respiratory Medicine, Oncology and Surgery, having authored 47 papers that have together received 1.1k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (15 papers), Endometrial and Cervical Cancer Treatments (9 papers), Testicular diseases and treatments (5 papers), Sarcoma Diagnosis and Treatment (4 papers), Uterine Myomas and Treatments (4 papers), Cancer therapeutics and mechanisms (2 papers), Multiple and Secondary Primary Cancers (2 papers) and Neuroendocrine Tumor Research Advances (2 papers). The work is most often cited by research in Reproductive Medicine (320 citations), Obstetrics and Gynecology (168 citations), Surgery (225 citations), Toxicology (27 citations) and Oncology (112 citations). Robert E. Slayton has collaborated with scholars based in United States and Singapore. Frequent co-authors include John A. Blessing, Charles P. Perlia, Arthur H. Rossof, Hugh M. Shingleton, Steven G. Silverberg, Robert C. Park, William Thomas Creasman, Philip Bonomi, Philip John DiSaia and Janet M. Wolter. Their work appears in journals such as Cancer, Gynecologic Oncology, Investigational New Drugs, Journal of Clinical Oncology and Cancer Chemotherapy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.